Clinical Trials Browser

Phase 1 × paricalcitol × Plasma cell × Clear all

NCT00258258 2013-02-01

Paricalcitol and Zoledronate in Treating Patients With Relapsed or Refractory Multiple Myeloma or Other Plasma Cell Disorders

Phase 1 Terminated

Multiple Myeloma, Neoplasms, Plasma Cell